Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Tamil Nadu: 66.2% have antibodies, two-fold increase since Oct 2020, indicates latest Serosurvey

Tamil Nadu: 66.2% have antibodies, two-fold increase since Oct 2020, indicates latest Serosurvey

Zee News
Monday, August 02, 2021 01:47:34 PM UTC

The latest survey results showcase a steep increase in antibodies in the state’s population, as the current 62% is up from the 31% seen in Oct/Nov2020 and the 29% seen in April 2020.

Chennai: A Serosurvey conducted by the Directorate of Public Health and Preventive Medicine in Tamil Nadu has indicated that 66.2% of the Southern Indian state’s population has developed antibodies to Covid-19. The presence of antibodies in the bloodstream shows that a person has either been infected with COVID-19 and developed antibodies to fight the virus or that the effect of vaccination is reflecting.    This survey (random blood tests) which was done in July 2021, covered 26,610 persons across urban and rural areas of Tamil Nadu. The latest survey results showcase a steep increase in antibodies in the state’s population, as the current 62% is up from the 31% seen in Oct/Nov2020 and the 29% seen in April 2020. 
Read full story on Zee News
Share this story on:-
More Related News
© 2008 - 2026 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us